FDA approves second Advanced Cell stem cell trial

Advanced Cell Technology said on Monday it had won U.S. Food and Drug Administration approval to try out human embryonic stem cells for treating macular degeneration, a common cause of vision loss.


Šis įrašas paskelbtas Kamieninių ląstelių tyrimai kategorijose.

Comments are closed.